GSDMD
Gasdermin D (GSDMD) is a protein that in humans is encoded by the GSDMD gene. It is a member of the gasdermin family of proteins, which are involved in the process of pyroptosis, a form of programmed cell death associated with inflammation.
Structure
GSDMD is composed of two domains: an N-terminal domain and a C-terminal domain. The N-terminal domain is responsible for the pore-forming activity of the protein, while the C-terminal domain acts as an inhibitory domain that prevents the N-terminal domain from forming pores in the absence of activation signals.
Function
GSDMD plays a crucial role in the immune response by mediating pyroptosis. Upon activation by inflammatory caspases such as caspase-1, caspase-4, caspase-5, and caspase-11, the protein is cleaved into its active N-terminal fragment. This fragment then translocates to the plasma membrane, where it forms pores that lead to cell swelling, lysis, and the release of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18).
Activation
The activation of GSDMD is tightly regulated by inflammatory caspases. These caspases are activated in response to various pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) that are recognized by pattern recognition receptors (PRRs) such as NOD-like receptors (NLRs) and Toll-like receptors (TLRs).
Role in Disease
Dysregulation of GSDMD and pyroptosis has been implicated in various inflammatory diseases, including sepsis, inflammatory bowel disease (IBD), and atherosclerosis. Additionally, GSDMD-mediated pyroptosis has been shown to play a role in the immune response to infections by various pathogens, including bacteria, viruses, and parasites.
Research
Ongoing research is focused on understanding the precise mechanisms of GSDMD activation and its role in disease. Therapeutic strategies targeting GSDMD and pyroptosis are being explored as potential treatments for inflammatory diseases and infections.
See also
References
External links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD